Jan 24, 2017 13:00 pm UTC| Business
NEW YORK, Jan. 24, 2017 -- While data breaches destroy customer confidence, impact revenues, attract large regulatory fines and cost C-levels their jobs, 76% of data security professionals believe in the maturity of...
Quotient Limited to Report Third Quarter Fiscal 2017 Financial Results and Host Conference Call
Jan 24, 2017 13:00 pm UTC| Business
JERSEY, Channel Islands, Jan. 24, 2017 -- Quotient Limited(NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter ended December 31, 2016 will be...
Nova LifeStyle Launches Blockchain-Based Site to Enhance E-Commerce Strategy
Jan 24, 2017 12:45 pm UTC| Business
LOS ANGELES, Jan. 24, 2017 -- Nova LifeStyle, Inc. (NASDAQ:NVFY), a U.S. based fast-growing, innovative designer, manufacturer and distributor of modern LifeStyle furniture, today announced the Company has launched an...
GasLog Partners LP Announces Pricing of its Public Offering of 3,750,000 Common Units
Jan 24, 2017 12:42 pm UTC| Business
MONACO, January 24, 2017 -- GasLog Partners LP ("GasLog Partners," the "Partnership" or "we") (NYSE: GLOP) today announced that it has priced its public offering of 3,750,000 common units at a price to the public of $20.50...
Jan 24, 2017 12:41 pm UTC| Business
NEW YORK, Jan. 24, 2017 -- Prospect Capital Corporation (NASDAQ:PSEC) (“Prospect”) announced today that Prospect has purchased an additional $16.0 million of first lien senior secured floating rate notes issued by Mity,...
Public Relations (PR) Tools Market Analysis, 2024
Jan 24, 2017 12:36 pm UTC| Business
Dublin, Jan. 24, 2017 -- Research and Markets has announced the addition of the "Public Relations (PR) Tools Market Analysis By Industry, By Solution, By Application, By Deployment, By Region And Segment...
Jan 24, 2017 12:30 pm UTC| Business
NEW YORK, Jan. 24, 2017 -- TG Therapeutics, Inc.(NASDAQ:TGTX) today announced that theU.S. Food and Drug Administration(FDA) has granted orphan drug designation covering the combination of TG-1101 (ublituximab), the...